Skip to main content

Table 4 Key Findings for the influence of country on treatment and access to chemotherapy

From: A systematic review of geographical variation in access to chemotherapy

Chamber-lain ‘14 [30] Chemotherapy prescribing volume ratios (PVR) compared for 15 drugs by country (England v Wales) Not adjusted P values pertain to receipt of one named chemotherapy in England compared with the same chemotherapy in Wales
e.g. Bevacizumab PVR =3.28 (2.59 to 4.14) P < 0.001
For a full list of all 15 drugs please refer to the paper.